Financial statements Pure Biologics
Balance sheet of Pure Biologics
Company age:
Age:
7 y. 11 m. 3 d.
Share capital:
Share capital:
102 600 PLN
Balance sheet data of PURE BIOLOGICS
|
Year
|
2018
|
2019
|
|---|---|---|
| Total assets | 6 578 406,65 | 21 785 461,74 |
| A. Fixed assets | 852 756,93 | 3 186 550,23 |
| B. Current assets | 5 725 649,72 | 18 598 911,51 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 6 578 406,65 | 21 785 461,74 |
| A. Equity | 2 220 887,13 | 7 213 522,18 |
| B. Liabilities and provisions for liabilities | 4 357 519,52 | 14 571 939,56 |
| I. Long-term liabilities | 446 117,74 | 2 542 718,61 |
| II. Short-term liabilities | 2 487 417,34 | 2 872 333,30 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.